How to have a data-driven discussion on gene and cellular therapies

As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.

Mary Dorholt, PharmD, October 28, 21

Gene therapies, today and tomorrow

By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...

April 12, 24

As more gene therapies come to market, payers need expanded options to protect their plans

August 28, 24

Understanding Hemophilia

Breaking down the challenges, therapies and costs associated with hemophilia.

Mary Dorholt, PharmD, March 15, 23

New Tests and Therapies Enable Personalized Cancer Treatment

Oncology is one of the most complex areas of medical care. Evernorth’s cancer consult service pairs subspecialists from leading cancer centers with community oncologists, improving access to the best ...

April 13, 23

PBMs and the drug pipeline: Anticipating tomorrow while affording today

October 04, 24

Outcomes 2024: How Evernorth manages the drug pipeline today and prepares for tomorrow

May 08, 24